StockData

Grail vs Personalis

GRAL and PSNL side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GRAL and PSNL compare

Grail is the larger company, worth 3.1 times as much as Personalis ($5.2B against $1.7B).

Grail grew revenue faster over the last twelve months (17.5% versus 16.9% for Personalis).

Personalis keeps more of each dollar of sales as profit, with a net margin of −148% compared with −244% at Grail.

Grail scores higher on the StockData Score (10 against 5 for Personalis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGRALPSNL
Size and price
Market cap$5.2B$1.7B
Share price$115.89$15.71
Change, 1 year36.7%96.1%
Change, 5 years–5.1%
Beta (5Y)2.491.87
Employees910260
StockData Score
Total score10 (better)5
Valuation score1 (better)0
Growth score2 (better)0
Performance score1 (better)0
Health score6 (better)5
Dividend score00
Valuation
P/S31.1×20.8× (better)
P/B2.1× (better)7.9×
FCF yield−6.0% (better)−6.4%
Fair value–$3.28
Margin of safety–−379%
Growth
Revenue growth (TTM)17.5% (better)16.9%
Revenue growth, 5Y average–−2.4%
Profitability
Gross margin–16.7%
Operating margin−347%−157% (better)
Net margin−244%−148% (better)
FCF margin−187%−133% (better)
Return on equity−17.3% (better)−62.1%
Return on invested capital−27.1% (better)−465%
Financial health
Debt / equity0.000.00
Interest coverage–−684.0×
Current ratio8.93 (better)4.53
Altman Z-score5.518.83 (better)
Piotroski F-score5 (better)4
Dividends and buybacks
Buyback yield–−8.0%
Shareholder yield0.00% (better)−8.0%
Ownership
Held by institutions87.6%79.6%
Held by insiders11.0%15.0%
Insider net buying, 12 months−$38.0M−$6.9M (better)
Short interest, % of float20.1%7.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.